Full formulary
Every product we supply, with composition, format, pack size, storage conditions, TGA category and current availability.
For doctors & nurse practitioners
How medicinal cannabis is lawfully prescribed in Australia, and how to obtain verified access to our formulary and clinical team.
Access pathways
Both let you prescribe an unapproved medicinal cannabis product. They differ in who they cover, how long approval takes, and how much reporting you carry.
| Special Access Scheme — Category B | Authorised Prescriber Scheme | |
|---|---|---|
| Covers | One named patient, one approval | A class of patients with a specified condition, under one authority |
| Approval needed before prescribing | Yes — TGA approval for that patient, plus any state or territory approval | Yes — once, to become an Authorised Prescriber; then no per‑patient TGA application |
| Typical use | Occasional prescribing, or a first patient | Prescribing regularly to a defined patient group |
| Applied for by | The prescribing practitioner, via the TGA SAS online system | The practitioner, supported by an ethics committee approval or endorsement from a specialist college |
| State & territory approval | Separately required in most jurisdictions for Schedule 8 products. The TGA SAS “single‑in” process notifies some states on your behalf — check the requirements where you practise. | |
| Ongoing reporting | Per approval, as conditioned | Six‑monthly reporting of patient numbers to the TGA |
| Where to apply | TGA — access pathways for medicinal cannabis | |
Professional obligations
In July 2025 Ahpra published specific guidance on medicinal cannabis prescribing and has since taken action against practitioners. Worth reading in full before you start.
Ahpra guidanceAccess
Set out here rather than left behind the login.
Every product we supply, with composition, format, pack size, storage conditions, TGA category and current availability.
Certificate of analysis for every released batch, searchable by batch number, downloadable as PDF.
Consumer medicine information and product documentation to support your consent conversation and your notes.
A direct line to our medical science liaison for product, formulation and pharmacology questions.
Practical help preparing SAS‑B submissions and Authorised Prescriber applications, including what the TGA typically asks for.
Sessions on pharmacology, formulations, titration principles and monitoring, delivered by independent clinicians.
Verified access
Australian law permits product information about unapproved medicines to be given to health professionals, not to the public. Rather than a tick‑box declaration, we check your registration.
We verify the registration number you give us against the AHPRA public register before issuing credentials, and we keep a record of that check. It usually takes less than one business day.
Fields marked * are required.